Utility of urinary liver-type fatty acid-binding protein as a predictor of renal dysfunction in Japanese patients with HIV receiving tenofovir ... View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2019-06-06

AUTHORS

Shinichi Hikasa, Shota Shimabukuro, Kyoko Hideta, Satoshi Higasa, Akihiro Sawada, Tazuko Tokugawa, Kuniyoshi Tanaka, Mina Yanai, Takeshi Kimura

ABSTRACT

BackgroundTenofovir disoproxil fumarate (TDF) is known to reduce estimated glomerular filtration rate (eGFR). It is clinically important to identify patients at high risk for renal dysfunction as early as possible. Among the tubular markers, urinary β2 microglobulin (Uβ2MG) is a well-known biomarker of TDF-related tubulopathy. However, renal dysfunction has often been occurred in patients receiving TDF with low Uβ2MG levels. Recently, urinary liver-type fatty acid–binding protein (UL-FABP) was suggested to be predictor of the progression of renal dysfunction. Thus, we focused on UL-FABP in patients receiving TDF with low Uβ2MG levels.MethodsA retrospective, observational, single-center study, between January 2013 and December 2016, was conducted. Two renal end points (> 25% decrement in eGFR and > 20 mL/min/1.73 m2 decrement relative to the baseline) were assessed. To estimate the effect of UL-FABP on time to the first event, log-rank test was performed.ResultsA total of 24 Japanese outpatients with human immunodeficiency virus receiving TDF were enrolled. The outcome each occurred in two patients during the follow-up period. UL-FABP levels ≥4.0 μg/g creatinine was significantly associated with > 25% decrement and > 20 mL/min/1.73 m2 decrement (p = 0.006 and 0.001, respectively).ConclusionBased on our preliminary analysis, UL-FABP levels ≥4.0 μg/g creatinine predict renal dysfunction in patients receiving TDF with low Uβ2MG levels. More... »

PAGES

12

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s40780-019-0140-8

DOI

http://dx.doi.org/10.1186/s40780-019-0140-8

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1116677813

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/31183158


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of pharmacy, The Hospital of Hyogo College of Medicine, 1-1, Mukogawa-cho, 663-8501, Nishinomiya, Hyogo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.272264.7", 
          "name": [
            "Department of pharmacy, The Hospital of Hyogo College of Medicine, 1-1, Mukogawa-cho, 663-8501, Nishinomiya, Hyogo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hikasa", 
        "givenName": "Shinichi", 
        "id": "sg:person.011425346455.71", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011425346455.71"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of pharmacy, The Hospital of Hyogo College of Medicine, 1-1, Mukogawa-cho, 663-8501, Nishinomiya, Hyogo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.272264.7", 
          "name": [
            "Department of pharmacy, The Hospital of Hyogo College of Medicine, 1-1, Mukogawa-cho, 663-8501, Nishinomiya, Hyogo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Shimabukuro", 
        "givenName": "Shota", 
        "id": "sg:person.011444204507.02", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011444204507.02"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of pharmacy, The Hospital of Hyogo College of Medicine, 1-1, Mukogawa-cho, 663-8501, Nishinomiya, Hyogo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.272264.7", 
          "name": [
            "Department of pharmacy, The Hospital of Hyogo College of Medicine, 1-1, Mukogawa-cho, 663-8501, Nishinomiya, Hyogo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hideta", 
        "givenName": "Kyoko", 
        "id": "sg:person.013020307455.23", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013020307455.23"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Hematology, Department of Internal Medicine, Hyogo College of Medicine, 1-1, Mukogawa-cho, 663-8501, Nishinomiya, Hyogo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.272264.7", 
          "name": [
            "Division of Hematology, Department of Internal Medicine, Hyogo College of Medicine, 1-1, Mukogawa-cho, 663-8501, Nishinomiya, Hyogo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Higasa", 
        "givenName": "Satoshi", 
        "id": "sg:person.01157262543.43", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01157262543.43"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Hematology, Department of Internal Medicine, Hyogo College of Medicine, 1-1, Mukogawa-cho, 663-8501, Nishinomiya, Hyogo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.272264.7", 
          "name": [
            "Division of Hematology, Department of Internal Medicine, Hyogo College of Medicine, 1-1, Mukogawa-cho, 663-8501, Nishinomiya, Hyogo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sawada", 
        "givenName": "Akihiro", 
        "id": "sg:person.015210631055.30", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015210631055.30"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Hematology, Department of Internal Medicine, Hyogo College of Medicine, 1-1, Mukogawa-cho, 663-8501, Nishinomiya, Hyogo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.272264.7", 
          "name": [
            "Division of Hematology, Department of Internal Medicine, Hyogo College of Medicine, 1-1, Mukogawa-cho, 663-8501, Nishinomiya, Hyogo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tokugawa", 
        "givenName": "Tazuko", 
        "id": "sg:person.01052363066.87", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01052363066.87"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of pharmacy, The Hospital of Hyogo College of Medicine, 1-1, Mukogawa-cho, 663-8501, Nishinomiya, Hyogo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.272264.7", 
          "name": [
            "Department of pharmacy, The Hospital of Hyogo College of Medicine, 1-1, Mukogawa-cho, 663-8501, Nishinomiya, Hyogo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tanaka", 
        "givenName": "Kuniyoshi", 
        "id": "sg:person.013460377060.20", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013460377060.20"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of pharmacy, The Hospital of Hyogo College of Medicine, 1-1, Mukogawa-cho, 663-8501, Nishinomiya, Hyogo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.272264.7", 
          "name": [
            "Department of pharmacy, The Hospital of Hyogo College of Medicine, 1-1, Mukogawa-cho, 663-8501, Nishinomiya, Hyogo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yanai", 
        "givenName": "Mina", 
        "id": "sg:person.015142021551.00", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015142021551.00"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of pharmacy, The Hospital of Hyogo College of Medicine, 1-1, Mukogawa-cho, 663-8501, Nishinomiya, Hyogo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.272264.7", 
          "name": [
            "Department of pharmacy, The Hospital of Hyogo College of Medicine, 1-1, Mukogawa-cho, 663-8501, Nishinomiya, Hyogo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kimura", 
        "givenName": "Takeshi", 
        "id": "sg:person.012173163322.36", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012173163322.36"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/labinvest.2009.14", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037052004", 
          "https://doi.org/10.1038/labinvest.2009.14"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10157-015-1144-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045575286", 
          "https://doi.org/10.1007/s10157-015-1144-9"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11906-010-0133-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047079940", 
          "https://doi.org/10.1007/s11906-010-0133-3"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11892-014-0513-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042697007", 
          "https://doi.org/10.1007/s11892-014-0513-1"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2019-06-06", 
    "datePublishedReg": "2019-06-06", 
    "description": "BackgroundTenofovir disoproxil fumarate (TDF) is known to reduce estimated glomerular filtration rate (eGFR). It is clinically important to identify patients at high risk for renal dysfunction as early as possible. Among the tubular markers, urinary \u03b22 microglobulin (U\u03b22MG) is a well-known biomarker of TDF-related tubulopathy. However, renal dysfunction has often been occurred in patients receiving TDF with low U\u03b22MG levels. Recently, urinary liver-type fatty acid\u2013binding protein (UL-FABP) was suggested to be predictor of the progression of renal dysfunction. Thus, we focused on UL-FABP in patients receiving TDF with low U\u03b22MG levels.MethodsA retrospective, observational, single-center study, between January 2013 and December 2016, was conducted. Two renal end points (>\u200925% decrement in eGFR and\u2009>\u200920\u2009mL/min/1.73\u2009m2 decrement relative to the baseline) were assessed. To estimate the effect of UL-FABP on time to the first event, log-rank test was performed.ResultsA total of 24 Japanese outpatients with human immunodeficiency virus receiving TDF were enrolled. The outcome each occurred in two patients during the follow-up period. UL-FABP levels \u22654.0\u2009\u03bcg/g creatinine was significantly associated with >\u200925% decrement and\u2009>\u200920\u2009mL/min/1.73\u2009m2 decrement (p\u2009=\u20090.006 and 0.001, respectively).ConclusionBased on our preliminary analysis, UL-FABP levels \u22654.0\u2009\u03bcg/g creatinine predict renal dysfunction in patients receiving TDF with low U\u03b22MG levels.", 
    "genre": "article", 
    "id": "sg:pub.10.1186/s40780-019-0140-8", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1052798", 
        "issn": [
          "2055-0294"
        ], 
        "name": "Journal of Pharmaceutical Health Care and Sciences", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "5"
      }
    ], 
    "keywords": [
      "urinary liver-type fatty acid-binding protein", 
      "liver-type fatty acid-binding protein", 
      "renal dysfunction", 
      "fatty acid-binding protein", 
      "disoproxil fumarate", 
      "acid-binding protein", 
      "urinary \u03b22-microglobulin levels", 
      "\u03b22-microglobulin levels", 
      "single-center study", 
      "renal end points", 
      "glomerular filtration rate", 
      "urinary \u03b22-microglobulin", 
      "retrospective observational study", 
      "human immunodeficiency virus", 
      "log-rank test", 
      "tenofovir disoproxil fumarate", 
      "microglobulin levels", 
      "tubular markers", 
      "Japanese outpatients", 
      "immunodeficiency virus", 
      "ResultsA total", 
      "filtration rate", 
      "Japanese patients", 
      "observational study", 
      "high risk", 
      "patients", 
      "dysfunction", 
      "\u03b22-microglobulin", 
      "end point", 
      "TDF", 
      "predictors", 
      "first event", 
      "levels", 
      "HIV", 
      "outpatients", 
      "creatinine", 
      "tubulopathy", 
      "decrement", 
      "fumarate", 
      "MethodsA", 
      "microglobulin", 
      "progression", 
      "biomarkers", 
      "outcomes", 
      "virus", 
      "total", 
      "risk", 
      "protein", 
      "markers", 
      "study", 
      "period", 
      "rate", 
      "events", 
      "test", 
      "effect", 
      "utility", 
      "preliminary analysis", 
      "time", 
      "analysis", 
      "point"
    ], 
    "name": "Utility of urinary liver-type fatty acid-binding protein as a predictor of renal dysfunction in Japanese patients with HIV receiving tenofovir disoproxil fumarate with low urinary \u03b22 microglobulin levels: a retrospective observational study", 
    "pagination": "12", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1116677813"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s40780-019-0140-8"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "31183158"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s40780-019-0140-8", 
      "https://app.dimensions.ai/details/publication/pub.1116677813"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-09-02T16:04", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220902/entities/gbq_results/article/article_818.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1186/s40780-019-0140-8"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s40780-019-0140-8'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s40780-019-0140-8'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s40780-019-0140-8'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s40780-019-0140-8'


 

This table displays all metadata directly associated to this object as RDF triples.

194 TRIPLES      21 PREDICATES      89 URIs      77 LITERALS      7 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s40780-019-0140-8 schema:about anzsrc-for:11
2 anzsrc-for:1103
3 schema:author N401e7e35c95b4865b27269fbf3630095
4 schema:citation sg:pub.10.1007/s10157-015-1144-9
5 sg:pub.10.1007/s11892-014-0513-1
6 sg:pub.10.1007/s11906-010-0133-3
7 sg:pub.10.1038/labinvest.2009.14
8 schema:datePublished 2019-06-06
9 schema:datePublishedReg 2019-06-06
10 schema:description BackgroundTenofovir disoproxil fumarate (TDF) is known to reduce estimated glomerular filtration rate (eGFR). It is clinically important to identify patients at high risk for renal dysfunction as early as possible. Among the tubular markers, urinary β2 microglobulin (Uβ2MG) is a well-known biomarker of TDF-related tubulopathy. However, renal dysfunction has often been occurred in patients receiving TDF with low Uβ2MG levels. Recently, urinary liver-type fatty acid–binding protein (UL-FABP) was suggested to be predictor of the progression of renal dysfunction. Thus, we focused on UL-FABP in patients receiving TDF with low Uβ2MG levels.MethodsA retrospective, observational, single-center study, between January 2013 and December 2016, was conducted. Two renal end points (> 25% decrement in eGFR and > 20 mL/min/1.73 m2 decrement relative to the baseline) were assessed. To estimate the effect of UL-FABP on time to the first event, log-rank test was performed.ResultsA total of 24 Japanese outpatients with human immunodeficiency virus receiving TDF were enrolled. The outcome each occurred in two patients during the follow-up period. UL-FABP levels ≥4.0 μg/g creatinine was significantly associated with > 25% decrement and > 20 mL/min/1.73 m2 decrement (p = 0.006 and 0.001, respectively).ConclusionBased on our preliminary analysis, UL-FABP levels ≥4.0 μg/g creatinine predict renal dysfunction in patients receiving TDF with low Uβ2MG levels.
11 schema:genre article
12 schema:isAccessibleForFree true
13 schema:isPartOf N425914dddd7a49bb979a1a441b101497
14 Na88449f7131b4ee0a91153fdbd807bee
15 sg:journal.1052798
16 schema:keywords HIV
17 Japanese outpatients
18 Japanese patients
19 MethodsA
20 ResultsA total
21 TDF
22 acid-binding protein
23 analysis
24 biomarkers
25 creatinine
26 decrement
27 disoproxil fumarate
28 dysfunction
29 effect
30 end point
31 events
32 fatty acid-binding protein
33 filtration rate
34 first event
35 fumarate
36 glomerular filtration rate
37 high risk
38 human immunodeficiency virus
39 immunodeficiency virus
40 levels
41 liver-type fatty acid-binding protein
42 log-rank test
43 markers
44 microglobulin
45 microglobulin levels
46 observational study
47 outcomes
48 outpatients
49 patients
50 period
51 point
52 predictors
53 preliminary analysis
54 progression
55 protein
56 rate
57 renal dysfunction
58 renal end points
59 retrospective observational study
60 risk
61 single-center study
62 study
63 tenofovir disoproxil fumarate
64 test
65 time
66 total
67 tubular markers
68 tubulopathy
69 urinary liver-type fatty acid-binding protein
70 urinary β2-microglobulin
71 urinary β2-microglobulin levels
72 utility
73 virus
74 β2-microglobulin
75 β2-microglobulin levels
76 schema:name Utility of urinary liver-type fatty acid-binding protein as a predictor of renal dysfunction in Japanese patients with HIV receiving tenofovir disoproxil fumarate with low urinary β2 microglobulin levels: a retrospective observational study
77 schema:pagination 12
78 schema:productId N4b2d529d3ed346bc9d8a9aab2ac9f17e
79 N8897f6d44ab346fea21edb7d5d3c0733
80 N920bd9d6652b413cab075d8cb23a8637
81 schema:sameAs https://app.dimensions.ai/details/publication/pub.1116677813
82 https://doi.org/10.1186/s40780-019-0140-8
83 schema:sdDatePublished 2022-09-02T16:04
84 schema:sdLicense https://scigraph.springernature.com/explorer/license/
85 schema:sdPublisher N07698deb72904a2eabbb8eabc45155e8
86 schema:url https://doi.org/10.1186/s40780-019-0140-8
87 sgo:license sg:explorer/license/
88 sgo:sdDataset articles
89 rdf:type schema:ScholarlyArticle
90 N07698deb72904a2eabbb8eabc45155e8 schema:name Springer Nature - SN SciGraph project
91 rdf:type schema:Organization
92 N401e7e35c95b4865b27269fbf3630095 rdf:first sg:person.011425346455.71
93 rdf:rest Ndfcc89efe6cd465694a383098a74c4bc
94 N425914dddd7a49bb979a1a441b101497 schema:volumeNumber 5
95 rdf:type schema:PublicationVolume
96 N4b2d529d3ed346bc9d8a9aab2ac9f17e schema:name dimensions_id
97 schema:value pub.1116677813
98 rdf:type schema:PropertyValue
99 N5dee2cc56c494e20ac61df67374f3524 rdf:first sg:person.01157262543.43
100 rdf:rest Nb2f0160836f14325a013f725af951e7e
101 N768bc8fcee5341a6ba2d6770926af753 rdf:first sg:person.012173163322.36
102 rdf:rest rdf:nil
103 N8897f6d44ab346fea21edb7d5d3c0733 schema:name doi
104 schema:value 10.1186/s40780-019-0140-8
105 rdf:type schema:PropertyValue
106 N920bd9d6652b413cab075d8cb23a8637 schema:name pubmed_id
107 schema:value 31183158
108 rdf:type schema:PropertyValue
109 Na88449f7131b4ee0a91153fdbd807bee schema:issueNumber 1
110 rdf:type schema:PublicationIssue
111 Nb2f0160836f14325a013f725af951e7e rdf:first sg:person.015210631055.30
112 rdf:rest Nfa46a7f5e5954b3e93aef230d03b105f
113 Nc99eae2f12644237b0c0839b7e03f066 rdf:first sg:person.013020307455.23
114 rdf:rest N5dee2cc56c494e20ac61df67374f3524
115 Nd22ac4a651434d289e9df5fe015c485f rdf:first sg:person.015142021551.00
116 rdf:rest N768bc8fcee5341a6ba2d6770926af753
117 Ndfcc89efe6cd465694a383098a74c4bc rdf:first sg:person.011444204507.02
118 rdf:rest Nc99eae2f12644237b0c0839b7e03f066
119 Ne0007f52821d415ea24d0bc063da1d4e rdf:first sg:person.013460377060.20
120 rdf:rest Nd22ac4a651434d289e9df5fe015c485f
121 Nfa46a7f5e5954b3e93aef230d03b105f rdf:first sg:person.01052363066.87
122 rdf:rest Ne0007f52821d415ea24d0bc063da1d4e
123 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
124 schema:name Medical and Health Sciences
125 rdf:type schema:DefinedTerm
126 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
127 schema:name Clinical Sciences
128 rdf:type schema:DefinedTerm
129 sg:journal.1052798 schema:issn 2055-0294
130 schema:name Journal of Pharmaceutical Health Care and Sciences
131 schema:publisher Springer Nature
132 rdf:type schema:Periodical
133 sg:person.01052363066.87 schema:affiliation grid-institutes:grid.272264.7
134 schema:familyName Tokugawa
135 schema:givenName Tazuko
136 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01052363066.87
137 rdf:type schema:Person
138 sg:person.011425346455.71 schema:affiliation grid-institutes:grid.272264.7
139 schema:familyName Hikasa
140 schema:givenName Shinichi
141 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011425346455.71
142 rdf:type schema:Person
143 sg:person.011444204507.02 schema:affiliation grid-institutes:grid.272264.7
144 schema:familyName Shimabukuro
145 schema:givenName Shota
146 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011444204507.02
147 rdf:type schema:Person
148 sg:person.01157262543.43 schema:affiliation grid-institutes:grid.272264.7
149 schema:familyName Higasa
150 schema:givenName Satoshi
151 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01157262543.43
152 rdf:type schema:Person
153 sg:person.012173163322.36 schema:affiliation grid-institutes:grid.272264.7
154 schema:familyName Kimura
155 schema:givenName Takeshi
156 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012173163322.36
157 rdf:type schema:Person
158 sg:person.013020307455.23 schema:affiliation grid-institutes:grid.272264.7
159 schema:familyName Hideta
160 schema:givenName Kyoko
161 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013020307455.23
162 rdf:type schema:Person
163 sg:person.013460377060.20 schema:affiliation grid-institutes:grid.272264.7
164 schema:familyName Tanaka
165 schema:givenName Kuniyoshi
166 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013460377060.20
167 rdf:type schema:Person
168 sg:person.015142021551.00 schema:affiliation grid-institutes:grid.272264.7
169 schema:familyName Yanai
170 schema:givenName Mina
171 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015142021551.00
172 rdf:type schema:Person
173 sg:person.015210631055.30 schema:affiliation grid-institutes:grid.272264.7
174 schema:familyName Sawada
175 schema:givenName Akihiro
176 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015210631055.30
177 rdf:type schema:Person
178 sg:pub.10.1007/s10157-015-1144-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045575286
179 https://doi.org/10.1007/s10157-015-1144-9
180 rdf:type schema:CreativeWork
181 sg:pub.10.1007/s11892-014-0513-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042697007
182 https://doi.org/10.1007/s11892-014-0513-1
183 rdf:type schema:CreativeWork
184 sg:pub.10.1007/s11906-010-0133-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047079940
185 https://doi.org/10.1007/s11906-010-0133-3
186 rdf:type schema:CreativeWork
187 sg:pub.10.1038/labinvest.2009.14 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037052004
188 https://doi.org/10.1038/labinvest.2009.14
189 rdf:type schema:CreativeWork
190 grid-institutes:grid.272264.7 schema:alternateName Department of pharmacy, The Hospital of Hyogo College of Medicine, 1-1, Mukogawa-cho, 663-8501, Nishinomiya, Hyogo, Japan
191 Division of Hematology, Department of Internal Medicine, Hyogo College of Medicine, 1-1, Mukogawa-cho, 663-8501, Nishinomiya, Hyogo, Japan
192 schema:name Department of pharmacy, The Hospital of Hyogo College of Medicine, 1-1, Mukogawa-cho, 663-8501, Nishinomiya, Hyogo, Japan
193 Division of Hematology, Department of Internal Medicine, Hyogo College of Medicine, 1-1, Mukogawa-cho, 663-8501, Nishinomiya, Hyogo, Japan
194 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...